🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I/Ib study of adoptively transferred T-cell receptor gene-e...
Status
Active Not Recruiting
Location
Providence Portland Medical Center
Start Date
2023-04-03
Trial ID
NCT05349890
Treatments Being Tested
The central hypothesis is that the addition of CDX-301 to CDX-1140 radicall...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2021-08-13
Trial ID
NCT04536077
Treatments Being Tested
The purpose of this study is to test a new way of treating the most common ...
Status
Terminated
Location
Albert Einstein College of Medicine
Start Date
2021-01-01
Trial ID
NCT04491084
Treatments Being Tested
This research study is being done to find out if the immunotherapy drugs ca...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2022-04-20
Trial ID
NCT05029999
Treatments Being Tested
This is a study to determine the maximum tolerated dose (MTD) for CDX-1140 ...
Status
Completed
Location
HonorHealth Research Insititute
Start Date
2017-12-01
Trial ID
NCT03329950
Treatments Being Tested
This phase I trial evaluates the safety and effectiveness of in situ immuno...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2023-01-09
Trial ID
NCT04616248
This phase II trial compares the effectiveness of cemiplimab with CDX-1140 ...
Status
Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2026-05-27
Trial ID
NCT06980038
The primary objective of this maintenance therapy study is to identify the ...
Status
Terminated
Location
HonorHealth Research Institute
Start Date
2022-12-15
Trial ID
NCT05484011
Treatments Being Tested
Background: Biliary tract carcinoma (BTC) is cancer of the slender tubes t...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2024-05-08
Trial ID
NCT05849480
Treatments Being Tested
This phase II trial tests whether pembrolizumab combined with bevacizumab w...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2024-03-12
Trial ID
NCT05231122